Future Outlook And Stock Price Performance For Caredx Inc (NASDAQ: CDNA)

In the last trading session, 3.3 million shares of the Caredx Inc (NASDAQ:CDNA) were traded, and its beta was 1.95. Most recently the company’s share price was $24.91, and it changed around $2.5 or 11.16% from the last close, which brings the market valuation of the company to $1.34B. CDNA currently trades at a discount to its 52-week high of $34.84, offering almost -39.86% off that amount. The share price’s 52-week low was $7.42, which indicates that the current value has risen by an impressive 70.21% since then. We note from Caredx Inc’s average daily trading volume that its 10-day average is 0.62 million shares, with the 3-month average coming to 744.70K.

Caredx Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.89. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended CDNA as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Caredx Inc is expected to report earnings per share of 0.15 for the current quarter.

Caredx Inc (NASDAQ:CDNA) trade information

Instantly CDNA has showed a green trend with a performance of 11.16% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 24.96 on recent trading dayincreased the stock’s daily price by 0.2%. The company’s shares are currently up 16.35% year-to-date, but still up 6.82% over the last five days. On the other hand, Caredx Inc (NASDAQ:CDNA) is 3.79% up in the 30-day period. We can see from the shorts that 4.39 million shares have been sold at a short interest cover period of 5.27 day(s).

The consensus price target as assigned by Wall Street analysts is $37.5, which translates to bulls needing to increase their stock price by 33.57% from its current value. Analyst projections state that CDNA is forecast to be at a low of $35 and a high of $40.

Caredx Inc (CDNA) estimates and forecasts

Caredx Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -9.05 percent over the past six months and at a 173.44% annual growth rate that is well above the industry average of 5.20%. The year-over-year growth rate is expected to be 18.52%, up from the previous year.

Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 84.56M in revenue for the current quarter. 6 analysts expect Caredx Inc to make 85.31M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 65.57M and 72.05M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 28.96%. Forecasts for the next quarter put sales growth at 18.40%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -21.96%. Caredx Inc earnings are expected to increase by 74.72% in 2025, but the outlook is positive 73.75% per year for the next five years.

CDNA Dividends

Caredx Inc’s next quarterly earnings report is expected to be released in March.

Caredx Inc (NASDAQ:CDNA)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.78% of Caredx Inc shares, and 95.67% of them are in the hands of institutional investors. The stock currently has a share float of 99.42%. Caredx Inc stock is held by 309.0 institutions, with ARK INVESTMENT MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 10.925% of the shares, which is about 5.7 million shares worth $88.56 million.

BLACKROCK INC., with 10.1283% or 5.29 million shares worth $82.1 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.38 shares worth $59.18 million, making up 4.43% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.52 shares worth around $37.8 million, which represents about 2.83% of the total shares outstanding.